• Adelaide

  Participated · Seed · Aug 2024

  Adelaide is an attention measurement platform for media and advertising. According to a recent SEC filing it raised $1.2M in the latest close as part of a $3M offering. The filing indicates eighteen investors participated in this close. Founded in 2019 by Diane deCordova and Marc Guldimann, Adelaide has now raised a total of $13.6M in reported equity funding. The article does not provide operating metrics or specific future plans.

• Cypris

  Participated · Series A · Jul 2024

  Cypris offers an AI-powered research platform and market intelligence ecosystem designed for R&D and innovation teams. Its platform surfaces LLM-driven insights, semantic search, advanced data monitoring and access to 500M+ global data points. The company also provides bespoke research via a team of data analysts working from a focused technical database. Cypris serves leading Fortune 100 companies, government agencies, universities, and research institutions. The company plans to use the new capital to accelerate scaling of its platform for global R&D teams. Cypris is led by CEO Steve Hafif and is based in New York City. Cypris is a market-intelligence platform built for research, development, and innovation teams that serves as a single ecosystem for global innovation data. Led by CEO Steve Hafif, the platform aggregates and curates a proprietary database of more than 500M global data points, updated daily. Datasets include research papers, patents, product launch news and other major sources, which the platform uses to generate automated, interactive reports. Users can run queries on keywords, competitor names or forward-looking concepts to receive reports on the historical and current status of innovation for fields or companies. The company raised a $4M Series A and intends to use the proceeds to expand development efforts and broaden its business reach. Cypris is based in New York.

• ERIN

  Participated · Equity · Oct 2022

  Erin offers an employee referral platform that automates the referral process from referral submission through bonus payment. The mobile app includes gamification and tracking features designed to keep employees engaged with talent-acquisition initiatives and increase converted referral hires. The solution includes an AI component aimed at career development for both employees and candidates. Its Internal Mobility feature matches employees with next-step roles to reduce turnover and bridge career development gaps, while a Referral Network add-on helps employees identify suitable positions for candidates. The company plans to use new funding to expand its business reach, drive innovative new features, and continue customer support.

• Instant Teams

  Participated · Series A · Mar 2022

  Instant Teams operates a remote talent marketplace that builds and manages remote teams drawn from a 26,000+ database of military-connected, remote-certified workers. The platform supplies enterprise and high-growth customers with pipelines of talent for customer support, sales, data analytics and operational support roles. Customers include Assurance IQ, Amazon, Walmart, Expensify, Seesaw and the Department of Defense. The company employs over 500 remote team members across the globe. Founded in 2016 by military spouses Liza Rodewald and Erica McMannes, Instant Teams focuses on expanding its corporate and enterprise offerings and growing its military market share. The company intends to use recent financing to accelerate its marketplace technology and corporate structure to support that expansion. Instant Teams operates a software-as-a-service platform called Arti that automates the process of building and managing distributed, pre-vetted teams and connects military spouses with remote work opportunities. The platform enforces four layers of vetting for candidates and provides connections to employers plus participation in customer Slack groups to keep workers engaged. Last year, workers on the platform contributed 40,000 hours of work to over 40 customers, with common roles in administration, marketing, customer success, and tech support. Cofounders Liza Rodewald (CEO) and Erica McMannes (COO) launched the product after manually testing their team-building process. With new funding, the company plans to hire executive leadership, scale sales, continue in-house product development, and grow its presence in Baltimore while Rodewald remains based in Honolulu. At the time of the announcement the company had an 11-member distributed team and eight open positions.

• Peptilogics

  Participated · Series A · Sep 2017

  Peptilogics is a clinical-stage biotechnology company focused on creating a new class of surgical therapeutics to address infections associated with implanted orthopedic hardware. Its lead candidate, zaloganan (PLG0206), rapidly penetrates biofilms to eradicate bacteria that standard antibiotics cannot reach and is the first drug specifically aimed at prosthetic joint infections (PJI). In a Phase 1b study, 13 of 14 patients (93%) remained infection-free 12 months after treatment, prompting the company to advance into a 240-patient Phase 2/3 pivotal trial scheduled to begin in December 2025. Zaloganan has secured QIDP, Orphan Drug, and Fast Track designations from the FDA, affording potential regulatory and market exclusivity advantages. The medical need is large: roughly 45,000 U.S. PJI cases occur annually, each costing health systems up to $390,000, and current surgical approaches fail up to half the time. Peptilogics has raised approximately $120 million in equity funding to date, in addition to significant non-dilutive grants from CARB-X, to finance its clinical and commercial plans.

No current team members are available.